메뉴 건너뛰기




Volumn 20, Issue 6, 2008, Pages 1245-1250

Symptomatic remission in elderly schizophrenia patients treated with long-acting risperidone

Author keywords

Antipsychotic; Efficacy; Long acting risperidone; Old age; Remission

Indexed keywords

RISPERIDONE;

EID: 54049108085     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610208007606     Document Type: Article
Times cited : (7)

References (17)
  • 1
    • 0004235298 scopus 로고
    • American Psychiatric Association (, 4th edn DSM-IV, Washington, DC: American Psychiatric Association
    • American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn (DSM-IV). Washington, DC: American Psychiatric Association.
    • (1994) Diagnostic and Statistical Manual of Mental Disorders
  • 3
    • 0023149065 scopus 로고
    • Comparative efficacy of long-acting depot and oral neuroleptic medications in preventing schizophrenic recidivism
    • Babiker, I. E. (1987). Comparative efficacy of long-acting depot and oral neuroleptic medications in preventing schizophrenic recidivism. Journal of Clinical Psychiatry, 48, 94-97.
    • (1987) Journal of Clinical Psychiatry , vol.48 , pp. 94-97
    • Babiker, I.E.1
  • 4
    • 0035115351 scopus 로고    scopus 로고
    • Antipsychotic medications and the elderly: Effects on cognition and implications for use
    • Byerly, M. J., Weber, M. T., Brooks, D. L., Snow, L. R., Worley, M. A., and Lescouflair, E. (2001). Antipsychotic medications and the elderly: effects on cognition and implications for use. Drugs and Aging, 18, 45-61.
    • (2001) Drugs and Aging , vol.18 , pp. 45-61
    • Byerly, M.J.1    Weber, M.T.2    Brooks, D.L.3    Snow, L.R.4    Worley, M.A.5    Lescouflair, E.6
  • 5
    • 0037012134 scopus 로고    scopus 로고
    • A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia
    • Csernansky, J. G., Mahmoud, R. and Brenner, R. (2002). A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia. New England Journal of Medicine, 346, 16-22.
    • (2002) New England Journal of Medicine , vol.346 , pp. 16-22
    • Csernansky, J.G.1    Mahmoud, R.2    Brenner, R.3
  • 7
    • 0003412410 scopus 로고
    • Revised edn pp, Washington, DC: U.S. Dept. of Health, Education, and Welfare
    • Guy, W. (1976). ECDEU Assessment Manual for Psychopharmacology. Revised edn (pp. 218-222). Washington, DC: U.S. Dept. of Health, Education, and Welfare.
    • (1976) ECDEU Assessment Manual for Psychopharmacology , pp. 218-222
    • Guy, W.1
  • 8
    • 34249314745 scopus 로고    scopus 로고
    • Remission in prognosis of functional outcome: A new dimension in the treatment of patients with psychotic disorders
    • Helldin, L., Kane, J. M., Karilampi, U., Norlander, T. and Archer, T. (2007). Remission in prognosis of functional outcome: a new dimension in the treatment of patients with psychotic disorders. Schizophrenia Research, 93, 160-168.
    • (2007) Schizophrenia Research , vol.93 , pp. 160-168
    • Helldin, L.1    Kane, J.M.2    Karilampi, U.3    Norlander, T.4    Archer, T.5
  • 9
    • 36248979096 scopus 로고    scopus 로고
    • New for old? Risperidone long acting injection in older patients
    • Hudson-Jessop, P., Hughes, B. and Brinkley, N. (2007). New for old? Risperidone long acting injection in older patients. Australasian Psychiatry, 15, 461-464.
    • (2007) Australasian Psychiatry , vol.15 , pp. 461-464
    • Hudson-Jessop, P.1    Hughes, B.2    Brinkley, N.3
  • 10
    • 0031983904 scopus 로고    scopus 로고
    • Guidelines for depot antipsychotic treatment in schizophrenia
    • Kane, J. M. et al. (1998). Guidelines for depot antipsychotic treatment in schizophrenia. European Neuropsychopharmacology, 8, 55-66.
    • (1998) European Neuropsychopharmacology , vol.8 , pp. 55-66
    • Kane, J.M.1
  • 12
    • 23444452244 scopus 로고    scopus 로고
    • Remission in schizophrenia: Results from a 1-year study of long-acting risperidone injection
    • Lasser, R., Bossie, C., Gharabawi, G. and Kane, J. (2005). Remission in schizophrenia: results from a 1-year study of long-acting risperidone injection. Schizophrenia Research, 77, 215-227.
    • (2005) Schizophrenia Research , vol.77 , pp. 215-227
    • Lasser, R.1    Bossie, C.2    Gharabawi, G.3    Kane, J.4
  • 13
    • 21244449074 scopus 로고    scopus 로고
    • Pharmacotherapy in schizophrenia - comparison of second generation antipsychotic agents
    • in Hebrew
    • Melamed, Y., Finkel, B., Barak, Y., Zipris, P., Oyffe, I., Weizman, A. and Bleich, A. (2005). Pharmacotherapy in schizophrenia - comparison of second generation antipsychotic agents. Harefuah, 144, 285-290, 301 (in Hebrew).
    • (2005) Harefuah , vol.144 , Issue.285-290 , pp. 301
    • Melamed, Y.1    Finkel, B.2    Barak, Y.3    Zipris, P.4    Oyffe, I.5    Weizman, A.6    Bleich, A.7
  • 14
    • 0032792585 scopus 로고    scopus 로고
    • Drug-induced cognitive impairment in the elderly
    • Moore, A. R. and O'Keeffe, S. T. (1999). Drug-induced cognitive impairment in the elderly. Drugs and Aging, 15, 15-28.
    • (1999) Drugs and Aging , vol.15 , pp. 15-28
    • Moore, A.R.1    O'Keeffe, S.T.2
  • 15
    • 0032859549 scopus 로고    scopus 로고
    • Older patients with schizophrenia: Challenges in the coming decades
    • Palmer, B. W., Heaton, S. C. and Jeste, D. V. (1999). Older patients with schizophrenia: challenges in the coming decades. Psychiatric Services, 50, 1178-1183.
    • (1999) Psychiatric Services , vol.50 , pp. 1178-1183
    • Palmer, B.W.1    Heaton, S.C.2    Jeste, D.V.3
  • 16
    • 33846284148 scopus 로고    scopus 로고
    • Prospective 6-month follow-up of patients prescribed risperidone long-acting injection: Factors predicting favorable outcome
    • Taylor, D. M.,, Young, C. and Patel, M. X. (2006). Prospective 6-month follow-up of patients prescribed risperidone long-acting injection: factors predicting favorable outcome. International Journal of Neuropsychopharmacology, 9, 685-694.
    • (2006) International Journal of Neuropsychopharmacology , vol.9 , pp. 685-694
    • Taylor, D.M.1    Young, C.2    Patel, M.X.3
  • 17
    • 33751327329 scopus 로고    scopus 로고
    • van Os, J., Drukker, M., à Campo, J., Meijer, J., Bak, M. and Delespaul, P. (2006). Validation of remission criteria for schizophrenia. American Journal of Psychiatry, 163, 2000-2002.
    • van Os, J., Drukker, M., à Campo, J., Meijer, J., Bak, M. and Delespaul, P. (2006). Validation of remission criteria for schizophrenia. American Journal of Psychiatry, 163, 2000-2002.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.